American Century Companies’s Teva Pharmaceuticals TEVA Stock Holding History

American Century Companies’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.8M	Buy	524,693 +55,058	+12%	+$1.83M	0.01%	1342
2026 Q1	$14.1M	Buy	469,635 +103,576	+28%	+$3.33M	0.01%	1323
2025 Q4	$11.4M	Buy	366,059 +31,128	+9%	+$767K	0.01%	1392
2025 Q3	$6.77M	Buy	334,931 +74,123	+28%	+$1.3M	﹤0.01%	1589
2025 Q2	$4.37M	Buy	260,808 +32,388	+14%	+$523K	﹤0.01%	1727
2025 Q1	$3.51M	Buy	228,420 +11,897	+5%	+$213K	﹤0.01%	1750
2024 Q4	$4.77M	Buy	216,523 +19,442	+10%	+$354K	﹤0.01%	1627
2024 Q3	$3.55M	Buy	197,081 +21,903	+13%	+$383K	﹤0.01%	1733
2024 Q2	$2.85M	Buy	175,178 +20,026	+13%	+$308K	﹤0.01%	1753
2024 Q1	$2.19M	Sell	155,152 -1,112,455	-88%	-$14M	﹤0.01%	1850
2023 Q4	$13.2M	Sell	1,267,607 -180,358	-12%	-$1.68M	0.01%	1033
2023 Q3	$14.8M	Sell	1,447,965 -524,576	-27%	-$4.88M	0.01%	909
2023 Q2	$14.9M	Buy	1,972,541 +129,565	+7%	+$1.05M	0.01%	889
2023 Q1	$16.3M	Sell	1,842,976 -89,691	-5%	-$887K	0.01%	834
2022 Q4	$17.6M	Buy	1,932,667 +28,011	+1%	+$244K	0.01%	767
2022 Q3	$15.4M	Sell	1,904,656 -158,783	-8%	-$1.4M	0.01%	742
2022 Q2	$15.5M	Sell	2,063,439 -140,822	-6%	-$1.23M	0.01%	763
2022 Q1	$20.7M	Buy	2,204,261 +1,694	+0.1%	+$14.1K	0.01%	684
2021 Q4	$17.6M	Buy	2,202,567 +133,560	+6%	+$1.21M	0.01%	731
2021 Q3	$20.2M	Sell	2,069,007 -88,519	-4%	-$829K	0.01%	679
2021 Q2	$21.4M	Buy	2,157,526 +164,113	+8%	+$1.74M	0.01%	655
2021 Q1	$23M	Buy	1,993,413 +111,100	+6%	+$1.27M	0.02%	617
2020 Q4	$18.2M	Buy	1,882,313 +32,560	+2%	+$312K	0.01%	636
2020 Q3	$16.7M	Buy	1,849,753 +628,246	+51%	+$6.65M	0.01%	583
2020 Q2	$15.1M	Sell	1,221,507 -368,419	-23%	-$4.17M	0.01%	582
2020 Q1	$14.3M	Sell	1,589,926 -777,174	-33%	-$7.96M	0.02%	520
2019 Q4	$23.2M	Sell	2,367,100 -794,857	-25%	-$7.1M	0.02%	480
2019 Q3	$21.8M	Buy	3,161,957 +394,355	+14%	+$3.02M	0.02%	471
2019 Q2	$25.5M	Buy	2,767,602 +844,992	+44%	+$10.2M	0.03%	465
2019 Q1	$30.1M	Buy	1,922,610 +265,171	+16%	+$4.68M	0.03%	436
2018 Q4	$25.6M	Buy	1,657,439 +358,110	+28%	+$7.34M	0.03%	444
2018 Q3	$28M	Buy	1,299,329 +305,040	+31%	+$7.08M	0.03%	456
2018 Q2	$24.2M	Sell	994,289 -156,127	-14%	-$3.18M	0.02%	482
2018 Q1	$19.7M	Buy	1,150,416 +40,375	+4%	+$788K	0.02%	512
2017 Q4	$21M	Sell	1,110,041 -495,886	-31%	-$7.46M	0.02%	506
2017 Q3	$28.3M	Sell	1,605,927 -390,468	-20%	-$8.79M	0.03%	464
2017 Q2	$66.3M	Buy	1,996,395 +204,688	+11%	+$6.34M	0.07%	335
2017 Q1	$57.5M	Buy	1,791,707 +120,041	+7%	+$4.1M	0.06%	350
2016 Q4	$60.6M	Sell	1,671,666 -1,223,591	-42%	-$48.9M	0.07%	339
2016 Q3	$133M	Buy	2,895,257 +331,520	+13%	+$17.3M	0.15%	200
2016 Q2	$129M	Sell	2,563,737 -33,076	-1%	-$1.76M	0.15%	196
2016 Q1	$139M	Buy	2,596,813 +41,284	+2%	+$2.42M	0.16%	182
2015 Q4	$168M	Buy	2,555,529 +819,677	+47%	+$50.7M	0.2%	143
2015 Q3	$98M	Buy	1,735,852 +102,592	+6%	+$6.65M	0.12%	225
2015 Q2	$96.5M	Sell	1,633,260 -1,333,813	-45%	-$82.3M	0.11%	252
2015 Q1	$185M	Sell	2,967,073 -1,590,059	-35%	-$92.4M	0.21%	142
2014 Q4	$262M	Buy	4,557,132 +172,265	+4%	+$9.6M	0.3%	90
2014 Q3	$236M	Buy	4,384,867 +134,217	+3%	+$7.11M	0.28%	104
2014 Q2	$223M	Buy	4,250,650 +3,688,500	+656%	+$189M	0.25%	105
2014 Q1	$29.7M	Sell	562,150 -445,480	-44%	-$20.6M	0.04%	466
2013 Q4	$40.4M	Buy	1,007,630 +708,380	+237%	+$27.9M	0.05%	396
2013 Q3	$11.3M	Buy	299,250 +650	+0.2%	+$25.4K	0.01%	674
2013 Q2	$11.7M	Buy	+298,600	New	+$11.6M	0.02%	632

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

American Century Companies's TEVA Position: Q2 2026 in Review

American Century Companies increased its Teva Pharmaceuticals (TEVA) stake by 12% in Q2 2026, buying an estimated $1.83M and bringing the position to 524,693 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #1342.

American Century Companies first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $262M in Q4 2014. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

American Century Companies held 524,693 shares of Teva Pharmaceuticals worth $17.8M as of Q2 2026.
American Century Companies bought 55,058 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.83M.
Teva Pharmaceuticals made up 0.01% of American Century Companies's portfolio in Q2 2026, its #1342 holding.
American Century Companies first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
American Century Companies's Teva Pharmaceuticals position peaked at $262M in Q4 2014.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.